Segment Information (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

The following table presents the measure of segment assets regularly provided to the CODM (in thousands):

	June 30, 2025		December 31, 2024
Cash, cash equivalents and short-term investments		34,708		40,784

The following table presents financial information, including significant segment expenses, which are regularly provided to the CODM and included within consolidated net loss (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Research and development:
Personnel	$	1,294		$	757		$	2,614		$	1,544
Stock-based compensation		438			81			873			187
Clinical and contract manufacturing		5,342			3,718			12,069			7,040
Other		(521	)		(409	)		(858	)		(922	)
General and administrative:	0
Personnel		1,038			1,568			2,765			2,995
Stock-based compensation		834			1,142			1,785			2,310
Consulting and professional costs		786			1,015			2,252			2,613
Other		684			970			1,329			1,748
Goodwill impairment charge		—			17,130			—			17,130
Fair value adjustment for contingent consideration		532			2,220			2,456			4,765
Total operating expenses		10,427			28,192			25,285			39,410
Loss from operations		(10,427	)		(28,192	)		(25,285	)		(39,410	)
Other segment items		(5,622	)		463			(5,794	)		532
Net loss	$	(16,049	)	$	(27,729	)	$	(31,079	)	$	(38,878	)